Trade Mark Journal No.2026/022 29 May 2026
WO0000001914800 (10,42)
Office of origin: United States of America
Date of International Registration:2 January 2026
Date of designation in the UK:
2 January 2026
International priority date claimed: 7 July 2025
(United States of America)
(99271058)
- Class 10
- Saliva collection devices for medical purposes; genetic testing apparatus for medical purposes.
- Class 42
- Software as a service (SaaS) services featuring software using artificial intelligence (AI) for medical purposes; providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) for medical purposes; software as a service (SaaS) services featuring software using artificial intelligence (AI) for managing electronic health records, scheduling and coordinating patient appointments, analyzing test results, responding to patient medical queries, interpreting patient medical history, genetic test results, and electronic health records, and predicting patient outcomes based on historical medical data for medical purposes; providing on-line non-downloadable software that enables users to analyze patient medical history, patient records, patient data, and medical information via a website; providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) for managing electronic health records, scheduling and coordinating patient appointments, analyzing test results, responding to patient medical queries, interpreting patient medical history, genetic test results, and electronic health records, and predicting patient outcomes based on historical medical data for medical purposes.
Bioscope.AI, Inc.
Representative: Harbour and Clark Ltd, Suite 4, The Works, West Street, Olney Buckinghamshire MK46 5HR UNITED KINGDOM